NASDAQ:BHTGBioHiTech Global Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding BioHiTech Global Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $1.60 -0.07 (-4.19 %) (As of 08/14/2020 04:00 PM ET) Add Compare Share Today's Range$1.53Now: $1.60▼$1.6650-Day Range$1.48MA: $1.86▼$2.5152-Week Range$1.01Now: $1.60▼$4.40Volume319,047 shsAverage Volume957,631 shsMarket Capitalization$28.84 millionP/E RatioN/ADividend YieldN/ABeta1.67 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media BioHiTech Global, Inc. provides an environmentally friendly solution for food waste disposal. The Company, through its subsidiaries, BioHiTech America, LLC and BioHiTech Europe Limited, offers its customers various technologies integrating technological, biological and mechanical engineering solutions for the control, reduction and/or reuse of organic waste. It has a distribution license to sell, lease, use, distribute and manufacture the Eco-Safe Digester product. The Eco-Safe Digester is a data-driven, network-based mechanical/biological technology, which transforms food waste into nutrient-neutral water that can be disposed of via conventional sanitary sewer systems. The Eco-Safe Digester may be used by businesses in food service, hospitality, healthcare, government, conference centers, education centers or stadiums. Its Internet enabled system, the BioHiTech Cloud, streams data from the digesters, collects information from system users and integrates business application data.Read More Beat the Market (BTM) Rank™ 3.5 Analyst's Opinion Consensus RatingBioHiTech Global has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $4.00, BioHiTech Global has a potential upside of 150.0% from its current price of $1.60.Amount of Analyst CoverageBioHiTech Global has only been the subject of 1 research reports in the past 90 days. Previous Next 2.5 Community Rank Outperform VotesBioHiTech Global has received 125 “outperform” votes. (Add your “outperform” vote.)Underperform VotesBioHiTech Global has received 129 “underperform” votes. (Add your “underperform” vote.)Community SentimentBioHiTech Global has received 50.79% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about BioHiTech Global and other stocks. Vote “Outperform” if you believe BHTG will outperform the S&P 500 over the long term. Vote “Underperform” if you believe BHTG will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldBioHiTech Global does not currently pay a dividend.Dividend GrowthBioHiTech Global does not have a long track record of dividend growth. Previous Next 1.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, BioHiTech Global insiders have not sold or bought any company stock.Percentage Held by Insiders36.90% of the stock of BioHiTech Global is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 6.66% of the stock of BioHiTech Global is held by institutions. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of BioHiTech Global is -2.76, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of BioHiTech Global is -2.76, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioBioHiTech Global has a P/B Ratio of 13.33. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.40 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Educational services Sub-IndustryN/A SectorBusiness Services Current SymbolNASDAQ:BHTG Previous Symbol CUSIPN/A CIK1590383 Webwww.biohitech.com Phone845-262-1081Debt Debt-to-Equity Ratio16.94 Current Ratio0.34 Quick Ratio0.32Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$4.22 million Price / Sales6.83 Cash FlowN/A Price / Cash FlowN/A Book Value$0.12 per share Price / Book13.33Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-7,620,000.00 Net Margins-170.21% Return on Equity-347.08% Return on Assets-14.53%Miscellaneous EmployeesN/A Outstanding Shares18,027,000Market Cap$28.84 million Next Earnings DateN/A OptionableNot Optionable $1.60 -0.07 (-4.19 %) (As of 08/14/2020 04:00 PM ET) 30 days | 90 days | 365 days | Advanced Chart Receive BHTG News and Ratings via Email Sign-up to receive the latest news and ratings for BHTG and its competitors with MarketBeat's FREE daily newsletter. BioHiTech Global (NASDAQ:BHTG) Frequently Asked Questions How has BioHiTech Global's stock been impacted by COVID-19 (Coronavirus)? BioHiTech Global's stock was trading at $1.71 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, BHTG stock has decreased by 6.4% and is now trading at $1.60. View which stocks have been most impacted by COVID-19. Do Wall Street analysts recommend investors buy shares of BioHiTech Global? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BioHiTech Global in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for BioHiTech Global. How were BioHiTech Global's earnings last quarter? BioHiTech Global Inc (NASDAQ:BHTG) issued its quarterly earnings results on Tuesday, June, 30th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.13) by $0.03. The firm had revenue of $1.36 million for the quarter. BioHiTech Global had a negative return on equity of 347.08% and a negative net margin of 170.21%. View BioHiTech Global's earnings history. What price target have analysts set for BHTG? 1 analysts have issued 12 month target prices for BioHiTech Global's shares. Their forecasts range from $4.00 to $4.00. On average, they anticipate BioHiTech Global's share price to reach $4.00 in the next year. This suggests a possible upside of 150.0% from the stock's current price. View analysts' price targets for BioHiTech Global. Has BioHiTech Global been receiving favorable news coverage? News coverage about BHTG stock has trended somewhat negative on Friday, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. BioHiTech Global earned a daily sentiment score of -1.3 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news about BioHiTech Global. Are investors shorting BioHiTech Global? BioHiTech Global saw a increase in short interest in June. As of June 15th, there was short interest totaling 34,300 shares, an increase of 44.1% from the May 31st total of 23,800 shares. Based on an average daily trading volume, of 177,300 shares, the short-interest ratio is currently 0.2 days. Currently, 0.3% of the shares of the company are sold short. View BioHiTech Global's Short Interest. Who are some of BioHiTech Global's key competitors? Some companies that are related to BioHiTech Global include Tarena International (TEDU), RYB Education (RYB), Inozyme Pharma (EDTK), Four Seasons Edu (Cayman) (FEDU), Zhongchao (ZCMD), ATA (ATAI), Keros Therapeutics (CLEU), Wah Fu Education Group (WAFU), CIBT Education Group (MBAIF), Scientific Learning (SCIL), National American University Holdngs (NAUH), PCS Edventures! (PCSV), ChineseInvestors.com (CIIX), Creative Learning (CLCN) and Legacy Education Alliance (LEAI). View all competitors. What other stocks do shareholders of BioHiTech Global own? Based on aggregate information from My MarketBeat watchlists, some companies that other BioHiTech Global investors own include Opko Health (OPK), Bellicum Pharmaceuticals (BLCM), Allena Pharmaceuticals (ALNA), Biocept (BIOC), BioNano Genomics (BNGO), Citius Pharmaceuticals (CTXR), Heat Biologics (HTBX), NVIDIA (NVDA), Onconova Therapeutics (ONTX) and Sorrento Therapeutics (SRNE). What is BioHiTech Global's stock symbol? BioHiTech Global trades on the NASDAQ under the ticker symbol "BHTG." Who are BioHiTech Global's major shareholders? BioHiTech Global's stock is owned by a number of institutional and retail investors. Top institutional shareholders include UBS Group AG (0.08%). Company insiders that own BioHiTech Global stock include Frank E Celli, James D Chambers and Robert A Joyce. View institutional ownership trends for BioHiTech Global. Which major investors are buying BioHiTech Global stock? BHTG stock was purchased by a variety of institutional investors in the last quarter, including UBS Group AG. Company insiders that have bought BioHiTech Global stock in the last two years include Frank E Celli, James D Chambers, and Robert A Joyce. View insider buying and selling activity for BioHiTech Global. How do I buy shares of BioHiTech Global? Shares of BHTG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is BioHiTech Global's stock price today? One share of BHTG stock can currently be purchased for approximately $1.60. How big of a company is BioHiTech Global? BioHiTech Global has a market capitalization of $28.84 million and generates $4.22 million in revenue each year. What is BioHiTech Global's official website? The official website for BioHiTech Global is www.biohitech.com. How can I contact BioHiTech Global? BioHiTech Global's mailing address is 80 RED SCHOOLHOUSE ROAD SUITE 101, CHESTNUT RIDGE NY, 10977. The company can be reached via phone at 845-262-1081 or via email at [email protected] This page was last updated on 8/14/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
